Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE-T: Iron and COPD Exercise Trial
NCT03050424Phase 2Unknown
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferric Carboxymaltose with Placebo (2 arms). Primary endpoint: Constant Rate Cycle Ergometry (75% Max Load) at 8 weeks. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03050424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050424.